Klinikum der Universität München (LMU Klinikum)

Consensus on acromegaly therapeutic outcomes: an update (2025) Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, et al. Journal article Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial (2025) Fietkau R, Ghadimi M, Grützmann R, Wittel UA, Jacobasch L, Uhl W, Croner RS, et al. Journal article Molekulares Tumorboard bei urologischen Tumoren: Hoffnung oder Enttäuschung? (2025) Gaisa NT, Eckstein M, Casuscelli J, Kalogirou C, Zschäbitz S, Dörffer N, Reis H Journal article, Review article Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis (2025) Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, et al. Journal article Entwicklung eines standardisierten Übergabebogens für kritisch kranke Früh- und Neugeborene zum Interhospitaltransport in Bayern (2025) Wolff J, Batzlsperger C, Brickmann C, Dahlem P, Eberhardt H, Fahlbusch F, Fiedler A, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3 (2025) Blobner J, Ruf V, Weller J, Teske N, Forbrig R, Thon N, Albert NL, et al. Journal article Efficacy and tolerability of fenfluramine with concomitant potassium bromide in patients with Dravet syndrome (2025) Pringsheim M, Kluger G, Strzelczyk A, Schubert-Bast S, Mayer T, Glauche B, Muhle H, et al. Journal article Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery (2025) Thomann B, Fechter T, Fischer J, Runz A, Roers J, Ludwig U, Grehn M, et al. Journal article VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article